During the past decade, G.B.Bietti Eye Foundation - IRCCS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "G.B.Bietti Eye Foundation - IRCCS" #1 collaborator was "European Vision Institute Clinical Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "G.B.Bietti Eye Foundation - IRCCS" are "Diabetic Macular Edema" (1 trials) and "High Risk Proliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "G.B.Bietti Eye Foundation - IRCCS" in a lesser frequency.

Most popular intervention types in "G.B.Bietti Eye Foundation - IRCCS" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intravitreous injection of ranibizumab" (1 trials), "Ozurdex" (1 trials) and "Panretinal Photocoagulation (PRP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "G.B.Bietti Eye Foundation - IRCCS" are 2 trials for "All" genders.

Currently, there are NaN active trials in "G.B.Bietti Eye Foundation - IRCCS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in G.B.Bietti Eye Foundation - IRCCS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in G.B.Bietti Eye Foundation - IRCCS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".